ESMO Blogs

09|27|24

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Gurdip Daffu, VP, Medical Strategy; Anne Marie Robertson, EVP, EVERSANA ONCOLOGY Commercialization™; Vanitha Sankaran, VP, Medical Strategy; Barry Vucsko, SVP, Strategic Development Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme […]